GGrantIndex
← Leaderboards

Nancy K. Mello

Mc Lean Hospital (Belmont, Ma)

$16,963,613
Attributed
$18,333,913
Total exposure
13
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.5M · FY200513
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$24,908,136 · 15

By mechanism

R01$12,537,863 · 6
P01$6,416,556 · 3
N01$2,902,778 · 1
T32$1,288,774 · 1
K05$1,059,942 · 1
P50$702,223 · 3

Top collaborators

Most similar at Mc Lean Hospital (Belmont, Ma)

Same institution · by research overlap

Others in their field

Top investigators on “Cocaine

Research focus

CocaineDrug AbuseMacaca MulattaClinical ResearchMenstrual CycleBuprenorphineBehavioralPharmaceutical PreparationsDoseDopamineDrug InteractionsSelf AdministrationNonhuman PrimatePublic Health Medicine (Field)ProgesteroneSelf MedicationNational Institute Of Drug AbuseChronicAddictionReinforcerBaseDrug Abuse ChemotherapyNeurobiologyEffective Therapy

Grant awards (54)

Sex/Gender and Nicotine Addiction: Hormones, Behavior and Neuroimaging$663,431
R01 · FY2013 · DA · contact PI
Sex/Gender and Nicotine Addiction: Hormones, Behavior and Neuroimaging$692,969
R01 · FY2012 · DA · contact PI
Preclinical Evaluation of Medications to Treat Polydrug Addiction$547,592
R01 · FY2012 · DA · contact PI
Buprenorphine: A Behavioral Analysis$386,521
R01 · FY2012 · DA · contact PI
Sex/Gender and Nicotine Addiction: Hormones, Behavior and Neuroimaging$694,837
R01 · FY2011 · DA · contact PI
Preclinical Evaluation of Medications to Treat Polydrug Addiction$549,606
R01 · FY2011 · DA · contact PI
Buprenorphine: A Behavioral Analysis$394,490
R01 · FY2011 · DA · contact PI
Sex/Gender Factors in Nicotine Addiction$341,387
R01 · FY2011 · DA · contact PI
Drug Abuse Research Training Program$103,893
T32 · FY2011 · DA · contact PI
Assessment of Potential Cocaine Pharmacotherapies in Monkeys$2,177,022
N01 · FY2010 · DA · contact PI
Sex/Gender and Nicotine Addiction: Hormones, Behavior and Neuroimaging$689,364
R01 · FY2010 · DA · contact PI
Preclinical Evaluation of Medications to Treat Polydrug Addiction$551,836
R01 · FY2010 · DA · contact PI
Buprenorphine: A Behavioral Analysis$398,475
R01 · FY2010 · DA · contact PI
Sex/Gender Factors in Nicotine Addiction$351,945
R01 · FY2010 · DA · contact PI
Drug Abuse Research Training Program$301,365
T32 · FY2010 · DA · contact PI
ASSESSMENT OF POTENTIAL COCAINE PHARMACOTHERAPIES IN MONKEYS$725,756
N01 · FY2009 · DA · contact PI
Preclinical Evaluation of Medications to Treat Polydrug Addiction$542,924
R01 · FY2009 · DA · contact PI
Buprenorphine: A Behavioral Analysis$402,500
R01 · FY2009 · DA · contact PI
Sex/Gender Factors in Nicotine Addiction$355,500
R01 · FY2009 · DA · contact PI
Drug Abuse Research Training Program$304,800
T32 · FY2009 · DA · contact PI
Buprenorphine: A Behavioral Analysis$402,500
R01 · FY2008 · DA · contact PI
Sex/Gender Factors in Nicotine Addiction$356,063
R01 · FY2008 · DA · contact PI
Drug Abuse Research Training Program$293,408
T32 · FY2008 · DA · contact PI
Biobehavioral Studies of Substance Abuse$117,612
K05 · FY2008 · DA · contact PI
Neurobiology of Nicotine: Hormones and Behavior$299,625
R01 · FY2007 · DA · contact PI
Drug Abuse Research Training Program$285,308
T32 · FY2007 · DA · contact PI
Biobehavioral Studies of Substance Abuse$117,612
K05 · FY2007 · DA · contact PI
Cocaine and Polydrug Abuse: New Medication Strategies$1,183,074
P01 · FY2006 · DA · contact PI
Biobehavioral Studies of Substance Abuse$117,612
K05 · FY2006 · DA · contact PI
Cocaine and Polydrug Abuse: New Medication Strategies$1,231,551
P01 · FY2005 · DA
Cocaine Abuse and the Role of Gonadal Steroid Hormones$395,000
R01 · FY2005 · DA
Buprenorphine: A Behavioral Analysis$389,383
R01 · FY2005 · DA
Biobehavioral Studies of Substance Abuse$117,612
K05 · FY2005 · DA
Cocaine and Polydrug Abuse: New Medication Strategies$1,195,832
P01 · FY2004 · DA
Cocaine Abuse and the Role of Gonadal Steroid Hormones$395,000
R01 · FY2004 · DA
Buprenorphine: A Behavioral Analysis$389,383
R01 · FY2004 · DA
Biobehavioral Studies of Substance Abuse$114,915
K05 · FY2004 · DA
Cocaine and Polydrug Abuse: New Medication Strategies$1,401,571
P01 · FY2003 · DA
Cocaine Abuse and the Role of Gonadal Steroid Hormones$395,000
R01 · FY2003 · DA
Buprenorphine: A Behavioral Analysis$389,383
R01 · FY2003 · DA
BIOBEHAVIORAL STUDIES OF SUBSTANCE ABUSE$119,070
K05 · FY2003 · DA
Cocaine and Polydrug Abuse: New Medication Strategies$1,404,528
P01 · FY2002 · DA
Cocaine Abuse and the Role of Gonadal Steroid Hormones$395,000
R01 · FY2002 · DA
Buprenorphine: A Behavioral Analysis$389,383
R01 · FY2002 · DA
BIOBEHAVIORAL STUDIES OF SUBSTANCE ABUSE$119,070
K05 · FY2002 · DA
CORE -- SCIENTIFIC$0
P01 · FY2002 · DA
NEUROENDOCRINE APPROACHES TO ANTI-COCAINE MEDICATIONS$0
P01 · FY2002 · DA
Buprenorphine: A Behavioral Analysis$389,383
R01 · FY2001 · DA
Cocaine Abuse and the Role of Gonadal Steroid Hormones$389,383
R01 · FY2001 · DA
BIOBEHAVIORAL STUDIES OF SUBSTANCE ABUSE$118,098
K05 · FY2001 · DA
EVALUATION OF THE EFFECTS OF NEW MEDICATIONS ON DRUG SELF-ADMINISTRATION$272,278
P50 · FY2000 · DA
BEHAVIORAL ENDOCRINOLOGY$272,278
P50 · FY2000 · DA
POLYDRUG ABUSE IN WOMEN$157,667
P50 · FY2000 · DA
BIOBEHAVIORAL STUDIES OF SUBSTANCE ABUSE$118,341
K05 · FY2000 · DA